Indikationen und Grenzen der ECMO-Therapie
- 56 Downloads
Zusammenfassung
Die vorliegende Arbeit beleuchtet die Möglichkeiten und Grenzen der modernen extrakorporalen Membranoxygenierung (ECMO) bei Herz- oder Lungenversagen. Da die Zahl der Anwendungen von extrakorporalen Lungen- und Herz‑/Lungenersatzverfahren in den letzten Jahren bei schwerstkranken Patienten dramatisch zugenommen hat, ist die Entscheidungsfindung zur sinnvollen Indikation und im Verlauf einer eventuellen Therapiezieländerung besonders schwierig geworden, besonders auch im Hinblick auf die komplexe Situation in der Organtransplantation in Deutschland. Es wird versucht, das Dilemma zwischen Daten aus großen kontrollierten Studien und epidemiologischen Untersuchungen und der Entscheidung beim individuellen Patienten näher zu beleuchten.
Schlüsselwörter
Kritische Erkrankung Herzversagen Ethik Therapie am Lebensende EpidemiologieIndications and limitations of ECMO therapy
Abstract
The present work sheds light on the possibilities and limitations of modern extracorporeal membrane oxygenation (ECMO) therapy in the case of heart or lung failure. Since the number of applications of extracorporeal lung and heart/lung replacement procedures has increased dramatically in the last few years in severely ill patients, decision-making for a meaningful indication and in the course of a possible therapy target change has become particularly difficult, especially with regard to the complex situation in organ transplantation in Germany. An attempt is made to elucidate the dilemma between data from large controlled trials and epidemiological studies and the patients’ individuality.
Keywords
Critical illness Heart failure Ethics Terminal care EpidemiologyNotes
Einhaltung ethischer Richtlinien
Interessenkonflikt
C. Karagiannidis, T. Bein und S. Weber-Carstens geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Literatur
- 1.Ahn C, Kim W, Cho Y et al (2016) Efficacy of extracorporeal cardiopulmonary resuscitation compared to conventional cardiopulmonary resuscitation for adult cardiac arrest patients: A systematic review and meta-analysis. Sci Rep 6:34208CrossRefGoogle Scholar
- 2.Bein T, Weber-Carstens S, Goldmann A et al (2013) Lower tidal volume strategy (approximately 3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS: The prospective randomized Xtravent-study. Intensive Care Med 39:847–856CrossRefGoogle Scholar
- 3.Bein T, Weber-Carstens S, Herridge M (2015) Extracorporeal life support, ethics, and questions at the bedside: How does the end of the pathway look? Intensive Care Med 41:1714–1715CrossRefGoogle Scholar
- 4.Braune S, Sieweke A, Brettner F et al (2016) The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med 42:1437–1444CrossRefGoogle Scholar
- 5.Combes A, Brechot N, Luyt CE et al (2018) Indications for extracorporeal support: Why do we need the results of the EOLIA trial? Med Klin Intensivmed Notfmed 113:21–25CrossRefGoogle Scholar
- 6.Combes A, Slutsky AS, Brodie D (2018) ECMO for severe acute respiratory distress syndrome. N Engl J Med 379:1091–1092PubMedGoogle Scholar
- 7.Del Sorbo L, Fan E, Nava S et al (2016) ECCO2R in COPD exacerbation only for the right patients and with the right strategy. Intensive Care Med 42:1830–1831CrossRefGoogle Scholar
- 8.Del Sorbo L, Pisani L, Filippini C et al (2015) Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: A matched cohort study with historical control. Crit Care Med 43:120–127CrossRefGoogle Scholar
- 9.Fried TR, Bradley EH, Towle VR et al (2002) Understanding the treatment preferences of seriously ill patients. N Engl J Med 346:1061–1066CrossRefGoogle Scholar
- 10.Huttmann SE, Magnet FS, Karagiannidis C et al (2018) Quality of life and life satisfaction are severely impaired in patients with long-term invasive ventilation following ICU treatment and unsuccessful weaning. Ann Intensive Care 8:38CrossRefGoogle Scholar
- 11.Huttmann SE, Windisch W, Storre JH (2015) Invasive home mechanical ventilation: Living conditions and health-related quality of life. Respiration 89:312–321CrossRefGoogle Scholar
- 12.Janssens U, Burchardi H, Duttge G, Erchinger R, Gretenkort P, Mohr M, Nauck F, Rothärmel S, Salomon F, Schmucker P, Simon A, Stopfkuchen H, Valentin A, Weiler N, Neitzke G (2012) Therapiezieländerung und Therapiebegrenzung in der Intensivmedizin. Medizinrecht 3ß(10):647–650. https://doi.org/10.1007/s00350-012-3247-6 (Positionspapier der Sektion Ethik der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin)CrossRefGoogle Scholar
- 13.Karagiannidis C (2018) EOLIA trial: Does ECMO confer a survival advantage in ARDS? Med Klin Intensivmed Notfmed. https://doi.org/10.1007/s00063-018-0511-1 CrossRefPubMedGoogle Scholar
- 14.Karagiannidis C, Brodie D, Strassmann S et al (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42:889–896CrossRefGoogle Scholar
- 15.Karagiannidis C, Kampe KA, Sipmann FS et al (2014) Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: Pathophysiological and technical considerations. Crit Care 18:R124CrossRefGoogle Scholar
- 16.Karagiannidis C, Strassmann S, Callegari J et al (2018) Evolving epidemiology of home mechanical ventilation: A rapidly growing challenge for patient care. Dtsch Med Wochenschr. https://doi.org/10.1055/a-0758-4512 CrossRefPubMedGoogle Scholar
- 17.Karagiannidis C, Windisch W (2016) Epidemiology and mortality of extracorporeal life support in Germany between 2007 and 2014. Med Klin Intensivmed Notfmed 111:556–559CrossRefGoogle Scholar
- 18.Miller LW, Rogers JG (2018) Evolution of left ventricular assist device therapy for advanced heart failure: A review. JAMA Cardiol 3:650–658CrossRefGoogle Scholar
- 19.Ortega-Deballon I, Hornby L, Shemie SD et al (2016) Extracorporeal resuscitation for refractory out-of-hospital cardiac arrest in adults: A systematic review of international practices and outcomes. Resuscitation 101:12–20CrossRefGoogle Scholar
- 20.Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 374:1351–1363CrossRefGoogle Scholar
- 21.Rahmel A (2018) Organ donation. Med Klin Intensivmed Notfmed. https://doi.org/10.1007/s00063-018-0513-z CrossRefPubMedGoogle Scholar
- 22.Sauer CM, Yuh DD, Bonde P (2015) Extracorporeal membrane oxygenation use has increased by 433 % in adults in the United States from 2006 to 2011. ASAIO J 61:31–36CrossRefGoogle Scholar
- 23.Schulte K, Borzikowsky C, Rahmel A et al (2018) Decline in organ donation in Germany. Dtsch Arztebl Int 115:463–468PubMedPubMedCentralGoogle Scholar
- 24.Fichtner F, Moerer O, Laudi S, Weber-Carstens S, Nothacker M, Kaisers U (2018) Beatmungstherapie und Extrakorporalverfahren bei akuter respiratorischer Insuffizienz. Dtsch Arztebl Int 115(50):840–847. https://doi.org/10.3238/arztebl.2018.0840 (Klinische Leitlinie)CrossRefGoogle Scholar